Vita Direnzo

Lecce, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Unusual anatomic variation: The posterior inferior cerebellar artery arising from the middle meningeal artery.

Unusual anatomic variation: The posterior inferior cerebellar artery arising from the middle meningeal artery.

Journal: The neuroradiology journal

Published: January 08, 2025

Prevalence of Fabry disease and GLA variants in young patients with acute stroke: The challenge to widen the screening. The Fabry-Stroke Italian Registry.

Prevalence of Fabry disease and GLA variants in young patients with acute stroke: The challenge to widen the screening. The Fabry-Stroke Italian Registry.

Journal: Journal of the neurological sciences

Published: September 12, 2023

Internuclear Ophthalmoplegia as an Isolated Symptom of Brainstem Wake-up Stroke Responsive to Intravenous Thrombolysis: Evidence from MRI.

Internuclear Ophthalmoplegia as an Isolated Symptom of Brainstem Wake-up Stroke Responsive to Intravenous Thrombolysis: Evidence from MRI.

Journal: Current medical imaging

Published: April 12, 2022

Gut-oriented interventions in patients with multiple sclerosis: fact or fiction?

Gut-oriented interventions in patients with multiple sclerosis: fact or fiction?

Journal: European review for medical and pharmacological sciences

Published: February 18, 2022

Gender differences in safety issues during Fingolimod therapy: Evidence from a real-life Relapsing Multiple Sclerosis cohort.

Gender differences in safety issues during Fingolimod therapy: Evidence from a real-life Relapsing Multiple Sclerosis cohort.

Journal: Brain and behavior

Published: June 19, 2017

Cerebrospinal fluid neurofilament light levels mark grey matter volume in clinically isolated syndrome suggestive of multiple sclerosis.

Cerebrospinal fluid neurofilament light levels mark grey matter volume in clinically isolated syndrome suggestive of multiple sclerosis.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: May 25, 2017

Lymphocyte subsets as biomarkers of therapeutic response in Fingolimod treated Relapsing Multiple Sclerosis patients.

Lymphocyte subsets as biomarkers of therapeutic response in Fingolimod treated Relapsing Multiple Sclerosis patients.

Journal: Journal of neuroimmunology

Published: November 02, 2016

The Cost of Relapsing-Remitting Multiple Sclerosis Patients Who Develop Neutralizing Antibodies during Interferon Beta Therapy.

The Cost of Relapsing-Remitting Multiple Sclerosis Patients Who Develop Neutralizing Antibodies during Interferon Beta Therapy.

Journal: PloS one

Published: March 31, 2016

Exploratory analysis of predictors of patient adherence to subcutaneous interferon beta-1a in multiple sclerosis: TRACER study.

Exploratory analysis of predictors of patient adherence to subcutaneous interferon beta-1a in multiple sclerosis: TRACER study.

Journal: Expert opinion on drug delivery

Published: March 01, 2016

Long-Term Data of Efficacy, Safety, and Tolerability in a Real-Life Setting of THC/CBD Oromucosal Spray-Treated Multiple Sclerosis Patients.

Long-Term Data of Efficacy, Safety, and Tolerability in a Real-Life Setting of THC/CBD Oromucosal Spray-Treated Multiple Sclerosis Patients.

Journal: Journal of clinical pharmacology

Published: September 02, 2015

Long-term cardiac safety and tolerability of fingolimod in multiple sclerosis: A postmarketing study.

Long-term cardiac safety and tolerability of fingolimod in multiple sclerosis: A postmarketing study.

Journal: Journal of clinical pharmacology

Published: February 17, 2015

A rare case of multiple sclerosis and McArdle disease.

A rare case of multiple sclerosis and McArdle disease.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Published: February 11, 2015

Showing 1-12 of 23

Last Updated: 09/26/2026